Superworth

Amgen forward PE AMGN

Share price divided by analysts' consensus earnings for the next twelve months, since 1994.

Today, Oct 23, 2026
18.6×
10-year median
14.5×
Against its 10-year history
100th
percentile: 0 is its lowest day, 100 its highest
10-year range
11.7× to 18.6×
Peer median
18.2×

Amgen's forward PE is 18.6× as of Oct 23, 2026.

That is above its ten-year median of 14.5×, higher than on 100% of days in the last ten years.

Over that time it ranged from 11.7× in May 2019 to 18.6× in Aug 2026.

The median for 8 large drugmakers of a similar size is 18.2×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far18.6×14.3×18.6×
202515.9×13.3×16.8×
202413.4×13.4×17.3×
202315.4×12.3×16.1×
202215.4×12.9×16.8×
202113.2×11.8×16.1×
202014.6×12.7×17.1×
201916.2×11.7×16.3×
201813.9×12.9×15.5×
201713.8×12.8×15.2×
201612.8×11.8×16.5×
201517.1×15.5×21.2×
201420.5×14.7×21.3×
201315.9×12.9×17.3×
201213.6×12.1×14.7×
201112.7×10.1×12.7×
201011.8×11.0×13.2×
200911.9×10.3×13.8×
200813.1×10.2×15.3×
200712.6×12.6×18.3×

Against its peers

Companies in Drug Manufacturers - General nearest Amgen's size, closest first, today.

CompanyForward PE
AMGNAmgen18.6×
GILDGilead Sciences17.2×
PFEPfizer10.9×
MRKMerck17.5×
BMYBristol-Myers Squibb10.4×
ABBVAbbVie19.0×
JNJJohnson & Johnson23.4×
LLYEli Lilly and33.9×
BIIBBiogen19.1×
Peer median18.2×

Where Amgen ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Amgen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.